ZEKHARIAH IDRO: Open Payments
NPI 1922416023 · INDIO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 51 payments from 6 companies in 2025. Trend: 2023 $672 · 2024 $386 · 2025 $570
Food & beverage: $470Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $203 |
| Arcutis Biotherapeutics, Inc. | 28 | $151 |
| Regeneron Healthcare Solutions, Inc. | 1 | $99 |
| UCB, Inc. | 1 | $45 |
| STRATA Skin Sciences, Inc. | 4 | $42 |
| Amgen Inc. | 2 | $30 |
Products named: DUPIXENT, Zoryve, Bimzelx, XTRAC, Otezla.
Industry payments across CA — which companies pay providers there.
